SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Easy Mark who wrote (321)3/30/1998 4:25:00 PM
From: John S. Baker  Read Replies (1) of 1510
 
I followed your reasoning ... and have no quibble with it ... with the exception of the following snippet:


> As best I can tell, the best probability distribution for when the efficacy of Remune is revealed is a bimodal distribution between now and next March with peaks in May 1998 and March 1999. <


How does one arrive at a bimodal distribution? Are the peaks at May 98 and Mar 99 due to the "planned end" of Phase III and the "possible early end" of Phase III (as in CYPB)?


If so, I would speculate that the two "modes" are not equal.


If that's *not* what you meant, then would you explain the derivation of your bimodal months?


Thanks in advance.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News